Dangerous Liaisons

By Chris Bode Dangerous Liaisons With a large portion of the US population taking multiple prescription drugs and supplements, the increased risk of drug interactions and side effects drives the need for better testing before the medicines reach patients. All illustrations © raquel aparicio My mother-in-law moved in with us when she was 82. As her physical condition gradually deteriorated, the number of medications she w

Written byChris Bode
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

My mother-in-law moved in with us when she was 82. As her physical condition gradually deteriorated, the number of medications she was taking for various ailments increased: two for high blood pressure, two to promote gastric motility, one for congestive heart failure, one synthetic thyroid hormone, an expectorant, and two inhalers for chronic obstructive pulmonary disease (COPD). In addition, there was the occasional antibiotic for recurrent pneumonia. The drugs were prescribed by at least three different groups of doctors, none of whom communicated with the others. It soon became difficult to tell a new malady from a side effect of one of the drugs, or a potentially harmful interaction between the combinations of chemicals in her system.

A year or two into her time with us, she started to have an irregular heartbeat, an arrhythmia. After EKGs, a Holter monitor, and stress tests, the arrhythmia was diagnosed as a side ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity 

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series